MDxHealth SA (MDXH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
24 Pages - GLDATA51008
$250.00

Summary

MdxHealth SA (MdxHealth), formerly OncoMethylome Sciences SA, develops and commercializes advanced epigenetic assays and service testing for the early detection of cancer and personalized treatment decisions. It offers clinical molecular diagnostics solutions and pharmaco molecular diagnostics solutions. The company’s products include ConfirmMDx, which detects absence or presence of prostate cancer; PredictMDx, which indicates patient response to therapy. Its product pipeline includes ConfirmMDx and RecurMDx for bladder cancer. The company's tests are based on its proprietary MSP methylation technology that assists physicians in the diagnosis of cancer. It also provides indications of cancer recurrence and prediction of response to a specific therapy. It also offers biomarker development services to many pharmaceutical companies. The company has operations in Belgium and the US. MdxHealth is headquartered in Herstal, Belgium.

MDxHealth SA (MDXH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MDxHealth SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MDxHealth SA, Medical Devices Deals, 2010 to YTD 2016 9
MDxHealth SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
MDxHealth SA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MdxHealth Enters into Agreement with Erasmus MC 11
MDxHealth And Ghent University Form Epigenomics Center 12
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 14
MdxHealth Enters Into An Agreement With Ghent University 16
OncoMethylome Sciences Enters Into An Agreement With GlaxoSmithKline Biologicals 17
Licensing Agreements 18
MDxHealth Enters Into Licensing Agreement With Takara Bio 18
Equity Offering 19
MdxHealth Raises USD15.4 Million in Private Placement of Shares 19
MDxHealth SA - Key Competitors 21
Key Employees 22
Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
MDxHealth SA, Pharmaceuticals & Healthcare, Key Facts, 2014 1
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MDxHealth SA, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MDxHealth SA, Deals By Therapy Area, 2010 to YTD 2016 8
MDxHealth SA, Medical Devices Deals, 2010 to YTD 2016 9
MDxHealth SA, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
MdxHealth Enters into Agreement with Erasmus MC 11
MDxHealth And Ghent University Form Epigenomics Center 12
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 14
MdxHealth Enters Into An Agreement With Ghent University 16
OncoMethylome Sciences Enters Into An Agreement With GlaxoSmithKline Biologicals 17
MDxHealth Enters Into Licensing Agreement With Takara Bio 18
MdxHealth Raises USD15.4 Million in Private Placement of Shares 19
MDxHealth SA, Key Competitors 21
MDxHealth SA, Key Employees 22
MDxHealth SA, Other Locations 23
MDxHealth SA, Subsidiaries 23

List of Figures
MDxHealth SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
MDxHealth SA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
MDxHealth SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
MDxHealth SA, Medical Devices Deals, 2010 to YTD 2016 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838